PATENT CLAIM ANALYSIS

Application Number: 15973281
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-02
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure relates to compositions and methods for treating or preventing a fibrotic disorder or disease.

Claim (Index 10):
The method according to  claim 1 , wherein the gene or encoded product comprises (a) ANKDD1A, ATP5G2, CHCHD10, DNAJC22, FGF5, FMO2, GNB2L1, GLTSCR2, HIGD2A, IFIH, MTUS1, RPS18, RPL18A, RPL31, RPL35A, RPL5, RPS18, RPS29, SPATA6 or any combination thereof; or (b) RPS6KA5, BIVM, ACTA1, KRT7, AMIGO3, CCDC102B, RPL10, TAF1D, ADAMTS5, LAMB3, CLCF1, EPB41L1, GAS2L3, IRAK3, LPAR3, PCBP2, PDE7B, TMTC1, FRMD4A, GDF10, OBSCN, PLEKHA6, SHC3 or any combination thereof.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 93.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14616690', '15397351', '15319254', '15022663', '15318553']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7782122356722813
- 35 USC 102 Novelty (BERT): 0.582583899384044
- Combined Prediction Score: 0.7586494020434575
- Mean Citation Score: 321.409978
- Max Citation Score: 664.3534
- Similarity Product: 366.6886564745664

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test